ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,582Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 151

$564K Total Retail Price of All Prescriptions

Rank: 44 out of 151

364 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 364 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 364 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 9,797 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
FUROSEMIDE 466 443 1 6
AMLODIPINE BESYLATE 415 401 2 3
LEVOTHYROXINE SODIUM 394 367 3 2
OMEPRAZOLE 335 302 4 4
SIMVASTATIN 304 279 5 1
PRAVASTATIN SODIUM 289 262 6 23
METOPROLOL TARTRATE 237 224 7 7
POTASSIUM CHLORIDE 213 201 8 19
WARFARIN SODIUM 213 213 8 9
DONEPEZIL HCL 186 186 10 15
ATORVASTATIN CALCIUM 182 182 11 16
HYDROCHLOROTHIAZIDE 164 163 12 13
FOSINOPRIL SODIUM 153 141 13 189
LISINOPRIL 151 149 14 5
NAMENDA 148 148 15 20
LOSARTAN POTASSIUM 132 127 16 12
METFORMIN HCL 128 100 17 8
GLIMEPIRIDE 127 125 18 58
ATENOLOL 125 125 19 11
CITALOPRAM HBR 120 120 20 18
DIGOXIN 120 120 20 39
TAMSULOSIN HCL 109 102 22 30
CARVEDILOL 109 97 22 22
CRESTOR 107 97 24 27
DIOVAN 107 82 24 33
CLOPIDOGREL 102 90 26 29
ESCITALOPRAM OXALATE 92 90 27 40
MIRTAZAPINE 92 85 27 28
CHLORTHALIDONE 91 80 29 222
METOPROLOL SUCCINATE 88 82 30 21
SPIRONOLACTONE 82 75 31 72
PANTOPRAZOLE SODIUM 80 73 32 34
GABAPENTIN 78 77 33 14
OXYCODONE-ACETAMINOPHEN 77 73 S2 34 66
RANITIDINE HCL 76 70 35 32
KLOR-CON M20 74 63 36 106
LANTUS 70 55 37 47
ALENDRONATE SODIUM 70 57 37 26
HYDROCODONE-ACETAMINOPHEN 67 65 S3 39 10
SERTRALINE HCL 65 65 40 25
QUETIAPINE FUMARATE 62 62 41 53
TRAZODONE HCL 60 58 42 48
PLAVIX 60 52 42 37
PHENYTOIN SODIUM EXTENDED 57 50 44 160
CARBIDOPA-LEVODOPA 53 53 45 82
PROPRANOLOL HCL 52 37 46 175
TRIAMTERENE-HCTZ 52 43 46 68
EVISTA 52 52 46 277
ISOSORBIDE MONONITRATE ER 51 43 49 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.